Today: 3 March 2026
Subscribe
Browse Category

Stock Market 15 October 2025

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia shares hit a 52-week high near $5.49 on Oct 14, then rose to $5.54 on Oct 15 after announcing major 5G contracts with Vodafone and Rakuten. The company’s Q2 sales beat expectations, though EPS missed slightly. Nokia’s board approved issuing 120 million new shares, raising the total to about 5.58 billion. Analyst consensus remains a Moderate Buy, with a $5.52 average target.
15 October 2025
··
NUAI Stock Rockets 85% on AI Data Center News – Is the Rally Sustainable?

NUAI Stock Rockets 85% on AI Data Center News – Is the Rally Sustainable?

NUAI shares jumped nearly 90% on Oct. 9 after New Era began Phase Two engineering at its 1-gigawatt Texas AI data center. The company restored Nasdaq compliance on Oct. 10, canceling a delisting hearing. NUAI closed at $3.30 on Oct. 14, up 80% from a week earlier. Analysts caution the surge is fueled by momentum and aggressive marketing as much as fundamentals.
15 October 2025
··
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

ABT shares closed at $128 on Oct. 15, down 3.5% for the day and about 2% for the week. Abbott reported Q3 revenue of $11.37 billion, up 6.9% year-over-year but slightly below estimates; adjusted EPS matched forecasts at $1.30. Medical Devices drove growth, while Diagnostics fell 6.6%. Investors sold off the stock after in-line results, with analysts maintaining a Hold rating and a $143.50 median price target.
15 October 2025
··
Dragonfly Energy (DFLI) Patent News Sends Stock Soaring – Will the Rally Last?

Dragonfly Energy (DFLI) Patent News Sends Stock Soaring – Will the Rally Last?

Dragonfly Energy (DFLI) shares surged up to 42% in pre-market trading Oct. 15 after the USPTO allowed a key battery-communication patent. The company reported preliminary Q3 net sales of about $16 million, up 26% year-over-year, and narrowed its adjusted EBITDA loss. Despite recent gains, DFLI stock remains down roughly 44% in 2025. Dragonfly faces Nasdaq delisting risk and heavy losses.
15 October 2025
···
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti Stock Skyrockets Amid Quantum Computing Boom – Bubble or Breakthrough?

Rigetti (RGTI) closed at $54.91 on Oct. 13, 2025, after surging over 25% intraday and gaining about 127% year-to-date. Recent jumps followed $11.5 million in new contracts and JPMorgan’s $10 billion “frontier” tech investment announcement. The company remains unprofitable, with $1.8 million Q2 revenue and a $39.7 million loss. Analysts’ price targets mostly sit far below current levels.
15 October 2025
··
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale Power’s stock surged 20.3% after its partner ENTRA1 signed a 6 GW SMR deployment deal with TVA, the largest such contract in U.S. history. The plan involves six 77-MWe NuScale reactors. Global SMR demand is rising, with utilities and tech firms backing new projects. NuScale remains unprofitable, burning about $95 million in cash per quarter as of mid-2025.
15 October 2025
···
Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar shares jumped 10.8% to $15.72 on Oct 14, breaking above their 200-day average after Goldman Sachs raised its price target and reports surfaced of possible Chinese curbs on solar panel overcapacity. The company posted a Q2 loss of $0.53 per share on $1.69 billion revenue, missing estimates. Canadian Solar launched new HiKu7 TOPCon panels and announced large battery storage projects in Ontario. Analyst consensus remains “Hold.”
15 October 2025
··
Palantir (PLTR) Stock Rockets on AI Hype & Major Contracts – Bubble or Boom?

Palantir (PLTR) Stock Rockets on AI Hype & Major Contracts – Bubble or Boom?

Palantir shares traded near $180 on Oct. 15, 2025, up about 360% year-on-year after landing a $10 billion U.S. Army contract and a £750 million UK defense deal. Q2 revenue hit $1 billion for the first time, up 48% from a year earlier. A leaked Army memo on security flaws briefly sent shares down 7.5%, but the stock rebounded. Analyst targets range widely, with a median of $150–$160.
15 October 2025
··
Bitfarms Stock Skyrockets 148% YTD on Bitcoin Boom and AI Pivot – Latest News & Outlook

Bitfarms Stock Skyrockets 148% YTD on Bitcoin Boom and AI Pivot – Latest News & Outlook

Bitfarms shares surged over 600% in six months, closing at $5.89 on Oct. 14 after eight straight daily gains and record trading volume. The rally follows Bitcoin’s run to $125,000, a CFO change, a 10% buyback, and a shift into AI data centers. Bitfarms secured $300 million financing for a Pennsylvania campus. Analysts remain cautious, with price targets below current levels and the company still unprofitable.
15 October 2025
···
BigBear.ai Stock Soars Amid AI Boom – What’s Behind BBAI’s Wild 2025 Ride?

BigBear.ai Stock Soars on New Defense Deals – Can BBAI’s Rally Continue?

BigBear.ai shares jumped 22% on Oct. 13 after announcing a new defense partnership, pushing the stock near $9 and more than doubling its value in 2025. Despite the rally, Q2 revenue fell 18% to $32.5 million and net loss widened to $228.6 million. Analysts remain cautious, with most rating the stock “Hold” and a $6 average price target. Trading volume spiked to 172 million shares on Oct. 14.
15 October 2025
·····
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

A federal judge on Oct. 14 upheld the U.S. government’s downgrade of Humana’s 2025 Medicare Advantage star rating from 4.5 to 3.5 stars, dismissing Humana’s lawsuit. The ruling leaves about 45% of Humana’s Medicare Advantage members in lower-rated plans and could cost the company an estimated $1 billion in lost federal bonus payments next year. Humana shares fell 3–4% on the news. The company said it may appeal.
15 October 2025
·
Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Guggenheim initiated Uber coverage with a Buy rating and $140 price target, citing its network, technology, and brand. The firm projects autonomous vehicles will handle about 20% of U.S. rideshare trips by 2035. Uber shares closed at $94 on Oct. 14, with analysts’ consensus 12-month target near $105–107. Recent catalysts include strong Q3 results and the acquisition of AI startup Segments.ai.
15 October 2025
··
Sable Offshore Corp (SOC) Stock Plummets on Legal Setback – What’s Next for the Embattled Oil Driller?

Sable Offshore Corp (SOC) Stock Plummets on Legal Setback – What’s Next for the Embattled Oil Driller?

Sable Offshore Corp. shares fell about 25% on October 15 after a California judge tentatively ruled against the company in a key pipeline dispute. The stock traded near its 52-week low at $13.70 midday. Sable faces lawsuits and criminal charges from state officials over alleged environmental violations and has threatened to bypass California with a tanker-based oil export plan. Analysts remain divided on the company’s prospects.
15 October 2025
··
Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology Group shares plunged 13% Tuesday to $129.75 after surging to nearly $150 earlier in the week, then rebounded 6% in pre-market trading Wednesday. The company unveiled new “ZeroFlap” optical transceivers and joined Arm’s Total Design ecosystem to co-develop custom AI silicon. Credo also filed for a $750 million stock offering and acquired Hyperlume for about $40–50 million. Revenue jumped 273% last quarter to $223 million.
15 October 2025
···
PNC Financial Stock Oversold – Q3 Earnings Beat & Analyst Upgrades Fuel Rebound Hopes

PNC Financial Stock Oversold – Q3 Earnings Beat & Analyst Upgrades Fuel Rebound Hopes

PNC Financial closed at $189.73 on October 15, 2025, nearly unchanged from a year earlier. The bank beat Q3 earnings estimates with EPS of $4.35 and revenue of $5.92 billion but issued cautious Q4 net interest income guidance. Shares briefly entered oversold territory last week amid market volatility. Analysts, including Piper Sandler and Wells Fargo, have raised price targets, citing solid fundamentals.
15 October 2025
··
Blaize Holdings (BZAI) Soars on AI Chip Deals and Partnerships – What’s Next for This Edge AI Stock?

Blaize Holdings (BZAI) Soars on AI Chip Deals and Partnerships – What’s Next for This Edge AI Stock?

Blaize Holdings shares jumped 45% in two weeks to $5.90 on October 15, 2025, after landing $176 million in AI contracts across Asia. The company’s sales pipeline now totals $725 million through 2027, and 2025 revenue guidance is $35–38 million, up from $3.8 million last year. Despite analyst debate, the consensus 12-month price target is $7.50. Shares remain well below their $19.25 post-IPO high.
15 October 2025
·
FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy shares have surged 150% in the past month, recently trading near $12 after Bloom Energy announced a $5 billion AI data-center deal. Fiscal Q3 revenue nearly doubled to $46.7 million, but net loss widened to $92.5 million on restructuring charges. The company cut 17% of its workforce and is targeting AI-driven power demand. Analysts remain cautious, with a consensus price target below current levels.
15 October 2025
·····
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion shares jumped 25% on Oct 14, closing at $7.84, after Merck exercised its option on the EVX-B3 vaccine, paying $7.5 million upfront with up to $592 million in milestones. Evaxion will present two-year Phase 2 data for its AI-designed melanoma vaccine at ESMO on Oct 17. The company also announced an upgrade to its AI-Immunology platform and maintains a “Strong Buy” rating from analysts.
15 October 2025
···
1 … 1,267 1,268 1,269 1,270 1,271 … 1,325
Go toTop